Paulina Bala

Paulina Bala

Auto-generated profile, based on publicly available information

Paulina Bala

Our Lady of Perpetual Help Hospital in Wołomin, 05-200 Wołomin, ul. Gdyńska 1/3, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in Archiv Euromedica
Verified
Journal Article
Closed access
ARAneta Rasińska
Aneta Rasińska
JJJustyna Jachimczak
Justyna Jachimczak
PRPiotr Rzyczniok
Piotr Rzyczniok
PBPaulina Bala
Paulina Bala
JMJustyna Matusik
Justyna Matusik
MKMateusz Kopczyński
Mateusz Kopczyński
Ackground: Delayed-onset muscle soreness (DOMS) is a common consequence of eccentric exercise, often impairing recovery and performance. Omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA and DHA, have been proposed as potential nutritional interventions to mitigate DOMS through anti-inflammatory and membrane-stabilizing mechanisms. Methods: A structured literature search of PubMed, Scopus, and Web of Science (2000–2024) identified 14 randomized controlled trials and clinical studies investigating the effects of omega-3 supplementation on DOMS and exercise-induced muscle damage (EIMD). Results: Most studies used daily doses of 1.8–3 g of combined EPA/DHA for at least 3–4 weeks. Findings suggest that omega-3 supplementation may reduce perceived muscle soreness 24–72 hours post-exercise and exert mild anti-inflammatory effects. However, heterogeneity in study design, dosage, duration, and outcome measures limits the comparability and generalizability of results. Conclusion: Omega-3 fatty acids may offer a modest adjunctive benefit in reducing DOMS and supporting recovery. Further well-controlled trials are needed to clarify dose–response relationships and population-specific effects.

12 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PRPiotr Rzyczniok
Piotr Rzyczniok
MKMateusz Kopczyński
Mateusz Kopczyński
ARAneta Rasińska
Aneta Rasińska
JMJustyna Matusik
Justyna Matusik
JJJustyna Jachimczak
Justyna Jachimczak
PBPaulina Bala
Paulina Bala
Introduction and Objective: The increasing global burden of mental health disorders, exacerbated by the COVID-19 pandemic and the limitations of traditional mental health systems, has accelerated interest in digital health solutions. Artificial intelligence (AI) has emerged as a transformative force in mental health care, offering tools for diagnosis, intervention, and patient monitoring. This review aims to explore current applications, opportunities, and ethical challenges of AI-based tools in mental health, with an emphasis on responsible and equitable deployment. Review Methods: A narrative literature review was conducted using PubMed, Scopus, Web of Science, and Google Scholar. Peer-reviewed articles published between 2014 and 2022 were considered, with a focus on interdisciplinary sources covering clinical psychology, digital health technologies, AI development, and medical ethics. Key themes were synthesized across domains to provide a holistic understanding. State of Knowledge: AI technologies, including chatbots, machine learning algorithms, and predictive analytics, are increasingly integrated into mental health services. They offer scalable solutions for screening, personalized intervention, and early risk detection. However, concerns remain about algorithmic bias, privacy, transparency, and the digital divide. The current body of evidence supports AI’s potential to complement—rather than replace—human care, particularly when integrated responsibly within clinical frameworks. Conclusion: AI holds significant promise in improving access, personalization, and efficiency in mental health care. To harness its benefits, interdisciplinary collaboration, robust ethical oversight, and patient-centered design are essential. Further research is needed to evaluate long-term outcomes and ensure AI systems uphold clinical integrity, equity, and trust.

12 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PRPiotr Rzyczniok
Piotr Rzyczniok
ARAneta Rasińska
Aneta Rasińska
WRWeronika Rasińska
Weronika Rasińska
ARAnna Rzyczniok
Anna Rzyczniok
JMJustyna Matusik
Justyna Matusik
MKMateusz Kopczyński
Mateusz Kopczyński
The influence of infectious diseases on the development of infertility continues to be an area of active research. This review explores how the microbial environment within the male reproductive system may contribute to infertility. It examines how certain pathogenic characteristics of microorganisms can lead to reproductive issues when inflammation occurs in the male urogenital tract, focusing on how such infections impact sperm quality - such as reducing sperm count, impairing motility, altering morphology, and diminishing fertilization potential. Additionally, the review addresses how the body’s immune response and its resistance mechanisms may play a role in sustaining chronic inflammation in male reproductive organs. Purpose: To delineate how specific microbial communities and pathogen-linked virulence traits contribute to male infertility by disrupting spermatogenesis, sperm function and local immune homeostasis in the urogenital tract. Material and Methods: Narrative literature review based on a systematic search of microbiology, andrology and urology studies that compared semen microbiota, immune markers and clinical outcomes between proven-fertile and infertile men; key in-vitro and animal mechanistic papers were also appraised to integrate pathophysiological insights. Findings: Infertile semen shows a reproducible shift from protective Gram-positive Lactobacillus/Corynebacterium spp. to opportunistic Escherichia coli, Gardnerella, anaerobic Bacteroides and coagulase-negative staphylococci. Uropathogenic E. coli fimbriae, toxins and stress proteins, high anti-lysozyme staphylococci and Chlamydia/Ureaplasma lipopolysaccharides induce sperm agglutination, oxidative DNA damage and apoptosis. Declines in seminal lysozyme, lactoferrin and zinc - particularly in chronic prostatitis or hyper-viscous semen - halve bactericidal capacity, allowing chronic inflammation to persist.

4 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ARAneta Rasińska
Aneta Rasińska
PRPiotr Rzyczniok
Piotr Rzyczniok
ARAnna Rzyczniok
Anna Rzyczniok
WRWeronika Rasińska
Weronika Rasińska
JJJustyna Jachimczak
Justyna Jachimczak
JMJustyna Matusik
Justyna Matusik
Lung cancer has, for several decades, been the second most frequently diagnosed malignancy and the leading cause of cancer death worldwide. It continues to pose a significant burden on healthcare systems and a serious challenge for clinicians and patients. The majority of patients present with advanced disease at diagnosis, and most survive less than five years. Although novel targeted therapies have been introduced in recent years, there remains a significant demand for treatments capable of improving response and prolonging survival while having minimal impact on quality of life. Recent clinical evidence supporting immunotherapeutic approaches indicates that they may represent the next major therapeutic breakthrough in lung cancer management. Non-small cell lung cancer (NSCLC), which accounts for about 85% of lung cancers, was once considered a non-immunogenic disease; yet, as with several other malignancies, emerging data suggest that in most cases, the lack of immune response is functional and can be therapeutically overcome. Purpose: To provide a comprehensive review of immunotherapy as an innovative therapeutic approach for non-small cell lung cancer (NSCLC), highlighting the role of key immune mechanisms and checkpoint inhibitors. Material and Methods: The authors conducted a detailed literature review examining the immune context of NSCLC, discussing the significance of PD-1/PD-L1 and CTLA-4 checkpoints, relevant clinical trials, and emerging biomarkers like PD-L1 expression and tumor mutational burden. Findings: Immunotherapy, particularly PD-1/PD-L1 inhibitors, substantially improves survival in advanced NSCLC and can be enhanced by combination strategies. Biomarkers help identify patients most likely to benefit while guiding treatment choices.

7 July 2025 in Humanities & Social Sciences Reviews
Verified
Journal Article
Open access
PDF file
ARAneta Rasińska
Aneta Rasińska
PRPiotr Rzyczniok
Piotr Rzyczniok
PBPaulina Bala
Paulina Bala
JJJustyna Jachimczak
Justyna Jachimczak
MKMateusz Kopczyński
Mateusz Kopczyński
JMJustyna Matusik
Justyna Matusik
Research objective: This study aims to analyze nutritional strategies that support brain health, focusing on intermittent fasting, caloric restriction, and the gut–microbiota–brain axis. The goal is to identify the biological mechanisms through which these interventions influence cognitive function and mental well-being. Methodology: A narrative literature review methodology was employed, synthesizing data from peer-reviewed journal articles, research reports, meta-analyses, and systematic reviews published in recent years in databases such as PubMed and ScienceDirect. Main conclusions: Intermittent fasting and caloric restriction were shown to enhance neurogenesis, neuroplasticity, and resistance to oxidative stress. The gut microbiota plays a critical role in modulating neurotransmission, immune functions, and the development of neurodegenerative and psychiatric disorders. Application of the study: The findings may be applied in the prevention of neurodegenerative diseases, as complementary strategies in the treatment of depression and anxiety, and in the development of personalized nutritional programs promoting brain health across various age groups. Originality/Novelty of the study: The study’s originality lies in integrating three dietary strategies into a single framework of brain health support. Special emphasis is placed on combining metabolic interventions with emerging insights into the gut microbiome’s role in brain function.

7 July 2025 in Humanities & Social Sciences Reviews
Verified
Journal Article
Open access
PDF file
ARAneta Rasińska
Aneta Rasińska
PRPiotr Rzyczniok
Piotr Rzyczniok
PBPaulina Bala
Paulina Bala
JJJustyna Jachimczak
Justyna Jachimczak
MKMateusz Kopczyński
Mateusz Kopczyński
JMJustyna Matusik
Justyna Matusik
Research objective: The aim of this study is to analyze the role of strength training as a preventive measure against sports-related orthopedic injuries. Methodology: A review of scientific literature on injury mechanisms and the impact of strength training on injury risk reduction was conducted. Main conclusions: Strength training, especially eccentric and functional exercises, significantly improves joint stability, strengthens muscles, and enhances neuromuscular control, leading to a decrease in injury incidence. Education of athletes and coaches on proper technique and load monitoring is also crucial. Application of the study: The findings can be used by coaches, physiotherapists, and athletes to design training programs that minimize injury risk and improve athletic performance. Originality/Novelty of the study: This paper integrates recent insights from exercise physiology and injury prevention, emphasizing a comprehensive approach to strength training as an effective preventive strategy.